A cross-sectional analysis of the development of response inhibition in children with chromosome 22q11.2 deletion syndrome

Frontiers in Psychiatry

Volumn 4, Issue AUG, 2013, Pages

  Shapiro, Heather M ^a   Wong, Ling M ^a   Simon, Tony J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

22q11.2 deletion syndrome; Childhood cognitive development; Developmental disorders; Executive function; Response inhibition

Indexed keywords

ADOLESCENT; AGE; ARTICLE; BEHAVIOR CONTROL; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; CHROMOSOME DELETION 22Q11; CHROMOSOME DELETION 22Q11.2; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INHIBITION (PSYCHOLOGY); MALE; MENTAL CAPACITY; NEUROANATOMY; QUANTITATIVE ANALYSIS; RESPONSE INHIBITION; RESPONSE TIME; RISK FACTOR; SCHOOL CHILD; TASK PERFORMANCE;

EID: 84884489046     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00081     Document Type: Article

References (70)

1. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci (2001) 24:167-202. doi:10.1146/annurev.neuro.24.1.167
2. Huizinga M, Dolan CV, van der Molen MW. Age-related change in executive function: developmental trends and a latent variable analysis. Neuropsychologia (2006) 44:2017-36. doi:10.1016/j.neuropsychologia.2006.01.010
3. Tillman CM, Thorell LB, Brocki KC, Bohlin G. Motor response inhibition and execution in the stop-signal task: development and relation to ADHD behaviors. Child Neuropsychol (2008) 14:42-59. doi:10.1080/09297040701249020
4. Urben S, van der Linden M, Barisnikov K. Development of the ability to inhibit a prepotent response: influence of working memory and processing speed. Br J Dev Psychol (2011) 29:981-98. doi:10.1111/j.2044-835X.2011.02037.x
5. Bunge SA, Dudukovic NM, Thomason ME, Vaidya CJ, Gabrieli JDE. Immature frontal lobe contributions to cognitive control in children: evidence from fMRI. Neuron (2002) 33:301-11. doi:10.1016/S0896-6273(01)00583-9
6. Durston S, Thomas KM, Yang Y, Ulug AM, Zimmerman RD, Casey BJ. A neural basis for the development of inhibitory control. Dev Sci (2002) 5:F9-16. doi:10.1111/1467-7687.00235
7. Nigg JT. On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol Bull (2000) 126:220-46. doi:10.1037/0033-2909.126.2.220
8. Wykes T, Reeder C, Corner J. The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia. Schizophr Res (2000) 46:241-53. doi:10.1016/S0920-9964(99)00233-9
9. Thoma P, Wiebel B, Daum I. Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder. Schizophr Res (2007) 92:168-80. doi:10.1016/j.schres.2007.02.004
10. Cannon TD, van Erp TGM, Bearden CE, Loewy R, Thompson P, Toga AW, et al. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 29:653-69. doi:10.1093/oxfordjournals.schbul.a007037
11. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry (2005) 162:71-8. doi:10.1176/appi.ajp.162.1.71
12. Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry (2006) 59:863-71. doi:10.1016/j.biopsych.2005.09.005
13. Snitz BE, MacDonald AW, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull (2006) 32:179-94. doi:10.1093/schbul/sbi048
14. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 160:636-45. doi:10.1176/appi.ajp.160.4.636
15. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 7:818-27. doi:10.1038/nrn1993
16. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry (1999) 56:940-5. doi:10.1001/archpsyc.56.10.940
17. Vorstman JAS, Morcus MEJ, Duijff SN, Klaassen PWJ, Heineman-de Boer JA, Beemer FA, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry (2006) 45:1104-13. doi:10.1097/01.chi.0000228131.56956.c1
18. Baker KD, Skuse DH. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry (2005) 186:115-20. doi:10.1192/bjp.186.2.115
19. Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R, et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet (1997) 61:620-9. doi:10.1086/515508
20. Robin NH, Shprintzen RJ. Defining the clinical spectrum of deletion 22q11.2. J Pediatr (2005) 147(1):90-6. doi:10.1016/j.jpeds.2005.03.007
21. Oskarsdóttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child (2004) 89:148-51. doi:10.1136/adc.2003.026880
22. Tézenas Du Montcel S, Mendizabai H, Aymé S, Lévy A, Philip N. Prevalence of 22q11 microdeletion. J Med Genet (1996) 33:719. doi:10.1136/jmg.33.8.719
23. Scambler PJ. The 22q11 deletion syndromes. Hum Mol Genet (2000) 9:2421-6. doi:10.1093/hmg/9.16.2421
24. Simon TJ, Bish JP, Bearden CE, Ding L, Ferrante S, Nguyen V, et al. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children. Dev Psychopathol (2005) 17:753-84. doi:10.1017/S0954579405050364
25. Bish JP, Ferrante SM, McDonald-McGinn D, Zackai E, Simon TJ. Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11.2 deletion syndrome. Dev Sci (2005) 8:36-43. doi:10.1111/j.1467-7687.2005.00391.x
26. Sobin C, Kiley-Brabeck K, Karayiorgou M. Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry (2005) 10:553-62. doi:10.1038/sj.mp.4001609
27. Sobin C, Kiley-Brabeck K, Karayiorgou M. Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry (2005) 162:1090-9. doi:10.1176/appi.ajp.162.6.1090
28. Gothelf D, Hoeft F, Hinard C, Hallmayer JF, Stoecker JVD, Antonarakis SE, et al. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome. Hum Brain Mapp (2007) 28:533-42. doi:10.1002/hbm.20405
29. Verbruggen F, Logan GD. Proactive adjustments of response strategies in the stop-signal paradigm. J Exp Psychol Hum Percept Perform (2009) 35:835-54. doi:10.1037/a0012726
30. Aron AR. From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol Psychiatry (2011) 69:55-68. doi:10.1016/j.biopsych.2010.07.024
31. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD. Conflict monitoring and cognitive control. Psychol Rev (2001) 108:624-52. doi:10.1037/0033-295X.108.3.624
32. Wechsler D. WISC-IV Technical and Interpretive Manual. San Antonio, TX: Psychological Corp (2003).
33. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: Psychological Corp (1999).
34. Casey BJ, Trainor RJ, Orendi JL, Schubert AB, Nystrom LE, Giedd JN, et al. A developmental functional MRI study of prefrontal activation during performance of a Go-No-Go task. J Cogn Neurosci (1997) 9:835-47. doi:10.1162/jocn.1997.9.6.835
35. Shapiro HM, Takarae Y, Harvey D, Cabaral M, Simon TJ. A cross-sectional study of the development of volitional control of spatial attention in children with chromosome 22q11.2 deletion syndrome. J Neurodev Disord (2012) 4(1):5. doi:10.1186/1866-1955-4-5
36. Carter CS, Barch DM. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull (2007) 33:1131-7. doi:10.1093/schbul/sbm081
37. Hazy TE, Frank MJ, O'Reilly RC. Towards an executive without a homunculus: computational models of the prefrontal cortex/basal ganglia system. Philos Trans R Soc Lond B Biol Sci (2007) 362:1601-13. doi:10.1098/rstb.2007.2055
38. Verbruggen F, Logan GD, Liefooghe B, Vandierendonck A. Short-term aftereffects of response inhibition: repetition priming or between-trial control adjustments? J Exp Psychol Hum Percept Perform (2008) 34:413-26. doi:10.1037/0096-1523.34.2.413
39. Ridderinkhof KR, van den Wildenberg WPM, Segalowitz SJ, Carter CS. Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn (2004) 56:129-40. doi:10.1016/j.bandc.2004.09.016
40. Koechlin E, Ody C, Kouneiher F. The architecture of cognitive control in the human prefrontal cortex. Science (2003) 302:1181-5. doi:10.1126/science.1088545
41. Casey BJ, Durston S. From behavior to cognition to the brain and back: what have we learned from functional imaging studies of attention deficit hyperactivity disorder? Am J Psychiatry (2006) 163:957-60. doi:10.1176/appi.ajp.163.6.957
42. Vink M, Kahn RS, Raemaekers M, van den Heuvel M, Boersma M, Ramsey NF. Function of striatum beyond inhibition and execution of motor responses. Hum Brain Mapp (2005) 25:336-44. doi:10.1002/hbm.20111
43. Jahfari S, Stinear CM, Claffey M, Verbruggen F, Aron AR. Responding with restraint: what are the neurocognitive mechanisms? J Cogn Neurosci (2010) 22:1479-92. doi:10.1162/jocn.2009.21307
44. Shashi V, Kwapil TR, Kaczorowski J, Berry MN, Santos CS, Howard TD, et al. Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res (2010) 181:1-8. doi:10.1016/j.pscychresns.2009.07.003
45. Bearden CE, van Erp TGM, Dutton RA, Lee AD, Simon TJ, Cannon TD, et al. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions. Cereb Cortex (2009) 19:115-26. doi:10.1093/cercor/bhn064
46. Dufour F, Schaer M, Debbané M, Farhoumand R, Glaser B, Eliez S. Cingulate gyral reductions are related to low executive functioning and psychotic symptoms in 22q 11.2 deletion syndrome. Neuropsychologia (2008) 46:2986-92. doi:10.1016/j.neuropsychologia.2008.06.012
47. Sugama S, Bingham PM, Wang PP, Moss EM, Kobayashi H, Eto Y. Morphometry of the head of the caudate nucleus in patients with velocardiofacial syndrome (del 22q11.2). Acta Paediatr (2000) 89:546-9. doi:10.1080/080352500750027826
48. Eliez S, Barnea-Goraly N, Schmitt JE, Liu Y, Reiss AL. Increased basal ganglia volumes in velo-cardio-facial syndrome (deletion 22q11.2). Biol Psychiatry (2002) 52:68-70. doi:10.1016/S0006-3223(02)01361-6
49. Kates WR, Burnette CP, Bessette BA, Folley BS, Strunge L, Jabs EW, et al. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol (2004) 19:337-42. doi:10.1177/088307380401900506
50. Simon TJ, Wu Z, Avants B, Zhang H, Gee JC, Stebbins GT. Atypical cortical connectivity and visuospatial cognitive impairments are related in children with chromosome 22q11.2 deletion syndrome. Behav Brain Funct (2008) 4:25. doi:10.1186/1744-9081-4-25
51. van Amelsvoort T, Daly E, Henry J, Robertson D, Ng V, Owen M, et al. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry (2004) 61:1085-96. doi:10.1001/archpsyc.61.11.1085
52. Romanos M, Ehlis A-C, Baehne CG, Jacob C, Renner TJ, Storch A, et al. Reduced NoGo-anteriorisation during continuous performance test in deletion syndrome 22q11.2. J Psychiatr Res (2010) 44:768-74. doi:10.1016/j.jpsychires.2010.02.001
53. Kates WR, Krauss BR, Abdulsabur N, Colgan D, Antshel KM, Higgins AM, et al. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome). Neuropsychologia (2007) 45:2863-73. doi:10.1016/j.neuropsychologia.2007.05.007
54. Debbané M, Lazouret M, Lagioia A, Schneider M, van de Ville D, Eliez S. Resting-state networks in adolescents with 22q11.2 deletion syndrome: associations with prodromal symptoms and executive functions. Schizophr Res (2012) 139:33-9. doi:10.1016/j.schres.2012.05.021
55. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci (1999) 2:861-3. doi:10.1038/13158
56. Sowell ER, Thompson PM, Holmes CJ, Jernigan TL, Toga AW. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci (1999) 2:859-61. doi:10.1038/13154
57. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 101:8174-9. doi:10.1073/pnas.0402680101
58. Srivastava S, Buonocore MH, Simon TJ. Atypical developmental trajectory of functionally significant cortical areas in children with chromosome 22q11.2 deletion syndrome. Hum Brain Mapp (2011) 33:213-23. doi:10.1002/hbm.21206
59. Gothelf D, Penniman L, Gu E, Eliez S, Reiss AL. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study. Schizophr Res (2007) 96:72-81. doi:10.1016/j.schres.2007.07.021
60. Kates WR, Antshel KM, Faraone SV, Fremont WP, Higgins AM, Shprintzen RJ, et al. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry (2011) 69:945-52. doi:10.1016/j.biopsych.2010.10.027
61. Schaer M, Debbané M, Bach Cuadra M, Ottet M-C, Glaser B, Thiran J-P, et al. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr Res (2009) 115:182-90. doi:10.1016/j.schres.2009.09.016
62. Kunwar A, Ramanathan S, Nelson J, Antshel KM, Fremont W, Higgins AM, et al. Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study. Schizophr Res (2012) 137:20-5. doi:10.1016/j.schres.2012.01.032
63. Takarae Y, Schmidt L, Tassone F, Simon TJ. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome. Cogn Affect Behav Neurosci (2009) 9:83-90. doi:10.3758/CABN.9.1.83
64. Baker K, Baldeweg T, Sivagnanasundaram S, Scambler P, Skuse D. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry (2005) 58:23-31. doi:10.1016/j.biopsych.2005.03.020
65. Shashi V, Keshavan MS, Howard TD, Berry MN, Basehore MJ, Lewandowski E, et al. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clin Genet (2006) 69:234-8. doi:10.1111/j.1399-0004.2006.00569.x
66. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry (2004) 161:1700-2. doi:10.1176/appi.ajp.161.9.1700
67. Glaser B, Debbané M, Hinard C, Morris MA, Dahoun SP, Antonarakis SE, et al. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome. Am J Psychiatry (2006) 163:537-9. doi:10.1176/appi.ajp.163.3.537
68. Campbell LE, Azuma R, Ambery F, Stevens A, Smith A, Morris RG, et al. Executive functions and memory abilities in children with 22q11.2 deletion syndrome. Aust N Z J Psychiatry (2010) 44:364-71. doi:10.3109/00048670903489882
69. Kates WR, Antshel KM, Abdulsabur N, Colgan D, Funke B, Fremont W, et al. A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome). Am J Med Genet B Neuropsychiatr Genet (2006) 141B:274-80. doi:10.1002/ajmg.b.30284
70. Vorstman JAS, Turetsky BI, Sijmens-Morcus MEJ, de Sain MG, Dorland B, Sprong M, et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology (2009) 34:739-46. doi:10.1038/npp.2008.132